Skip to content

Write a review and win an AirPods Pro or MacBook Air - See the draw

Medical imaging

Clario (Thermo Fisher)

Leading endpoint data capture platform combining eCOA,cardiac safety,medical imaging,precision motion,and respiratory endpoints. Acquired by Thermo Fisher for $8.9B. Supported 19,000+ trials and 870+ regulatory approvals.

Medical imaging

Vendor description

About

Leading endpoint data capture platform combining eCOA,cardiac safety,medical imaging,precision motion,and respiratory endpoints. Acquired by Thermo Fisher for $8.9B. Supported 19,000+ trials and 870+ regulatory approvals.

Positioning

Enterprise multi-modal endpoint data capture platform

Best for

Complex multi-endpoint trials,Cardiac safety,Medical imaging,eCOA + imaging combined

Strengths
  • Only platform combining eCOA,cardiac safety,imaging,motion,respiratory
  • 19,000+ trials supported
  • 870+ regulatory approvals
  • Thermo Fisher ecosystem integration
Limitations
  • Premium pricing
  • Complex implementation
  • Tied to Thermo Fisher ecosystem

Approved customer reviews

Write a review
No reviews yet

Be the first customer to share verified experience with this vendor.

Pricing

Price band

$

Key facts

HQ countryUnited States
GeographyGlobal
Service modelFull-service + Technology
Study phasesPhase I, Phase II, Phase III, Phase IV
Trial scaleMedium,Large,Global
Therapeutic areasOncology, Cardiovascular, Respiratory, Neurology, Rare diseases, Ophthalmology

Related vendors

Editorial ranking

See how Clario (Thermo Fisher) compares - best Medical imaging vendors for clinical trials.